article thumbnail

Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years

Heart BMJ

Background Health inequalities in cardiovascular care have been identified in the UK. The sociodemographic characteristics of patients undergoing intervention for aortic stenosis (AS) in England, and the impact of COVID-19, is unknown. These variations have widened over time.

article thumbnail

Impact of gender, ethnicity and social deprivation on access to surgical or transcatheter aortic valve replacement in aortic stenosis: a retrospective database study in England

Open Heart

Objective To assess gender, ethnicity, and deprivation-based differences in provision of aortic valve replacement (AVR) in England for adults with aortic stenosis (AS). We separately used HES-linked Clinical Practice Research Datalink (CPRD) to identify people with AVR and evaluate the timeliness of their procedure (CPRD-AVR cohort).

article thumbnail

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

DAIC

1 Low/zero fluoroscopy safety was evaluated further by a secondary analysis of data from electronic health records from 45 hospitals within the Mercy Health integrated hospital network, comparing PAEs between procedures with low fluoroscopy (two minutes or fewer) versus conventional fluoroscopy (three minutes or longer).1 Int J Stroke.

Ablation 105
article thumbnail

National Hispanic Heritage Month 2023 Faculty Spotlight: Dr. Fatima Rodriguez

Cardiometabolic Health Congress

After watching her mother receive life-saving cardiac surgery for critical rheumatic mitral stenosis, 14-year-old Dr. Rodriguez became determined to become a cardiologist. This experience also motivated her interest in addressing language barriers and social determinants of health that impede access to high-quality, evidence-based care.

article thumbnail

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

The primary safety endpoint was incidence of early onset (within seven days) primary adverse events; atrio-esophageal fistula (within 90 days); cardiac tamponade or perforation (within 30 days); and PV stenosis (within 12 months). Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.

article thumbnail

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

DAIC

This prevalence underscores the urgent need for heightened awareness, prevention strategies, and access to quality healthcare services to combat the detrimental effects of cardiovascular diseases on public health. “At About 276,000 patients have undergone a TAVR procedure in the United States.

article thumbnail

Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank

Open Heart

VHD incidence was determined using International Classification of Disease-10 codes for aortic stenosis (AS), aortic regurgitation (AR), mitral stenosis, mitral regurgitation (MR) and mitral valve prolapse. Conclusion VHD continues to constitute a significant public health burden, with MR and AS being the most common.